These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2279644)

  • 1. Prospective randomized comparison of esophageal variceal sclerotherapy agents: sodium tetradecyl sulfate versus sodium morrhuate.
    McClave SA; Kaiser SC; Wright RA; Edwards JL; Kranz KR
    Gastrointest Endosc; 1990; 36(6):567-71. PubMed ID: 2279644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective randomized comparison of sodium tetradecyl sulfate and polidocanol as variceal sclerosing agents.
    Bhargava DK; Singh B; Dogra R; Dasarathy S; Sharma MP
    Am J Gastroenterol; 1992 Feb; 87(2):182-6. PubMed ID: 1734694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective, randomized trial of hypertonic glucose water and sodium tetradecyl sulfate for gastric variceal bleeding in patients with advanced liver cirrhosis.
    Chang KY; Wu CS; Chen PC
    Endoscopy; 1996 Aug; 28(6):481-6. PubMed ID: 8886633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind randomized controlled trial comparing sodium tetradecyl sulphate and ethanolamine oleate in the sclerotherapy of bleeding oesophageal varices.
    Chan AC; Chung SC; Sung JY; Leung JW; Li AK
    Endoscopy; 1993 Oct; 25(8):513-7. PubMed ID: 8287811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variceal sclerosing agents.
    Brooks WS
    Am J Gastroenterol; 1984 May; 79(5):424-8. PubMed ID: 6609635
    [No Abstract]   [Full Text] [Related]  

  • 6. Prospective randomized comparison of sodium tetradecyl sulphate & polidocanol for oesophageal variceal sclerotherapy.
    Ravi M; Kate V; Ananthakrishnan N
    Indian J Med Res; 2001 Jun; 113():228-33. PubMed ID: 11816957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Injection sclerotherapy for variceal bleeding in patients with hepatocellular carcinoma: cyanoacrylate versus sodium tetradecyl sulphate.
    Sung JJ; Yeo W; Suen R; Lee YT; Chung SC; Chan FK; Johnson PJ
    Gastrointest Endosc; 1998 Mar; 47(3):235-9. PubMed ID: 9540875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sclerotherapy in noncirrhotic portal fibrosis.
    Chawla YK; Dilawari JB; Dhiman RK; Goenka MK; Bhasin DK; Kochhar R; Singh K; Kaur U
    Dig Dis Sci; 1997 Jul; 42(7):1449-53. PubMed ID: 9246045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trial of sclerosing agents in patients with oesophageal varices.
    Kitano S; Iso Y; Yamaga H; Hashizume M; Higashi H; Sugimachi K
    Br J Surg; 1988 Aug; 75(8):751-3. PubMed ID: 3048533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of paraesophageal varices and gastric varices in patients achieving variceal obliteration by banding ligation and by injection sclerotherapy.
    Lo GH; Lai KH; Cheng JS; Huang RL; Wang SJ; Chiang HT
    Gastrointest Endosc; 1999 Apr; 49(4 Pt 1):428-36. PubMed ID: 10202054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of 5% ethanolamine oleate versus 5% sodium morrhuate for sclerotherapy of oesophageal varices.
    Kitano S; Wada H; Yamaga H; Hashizume M; Koyanagi N; Iwanaga T; Iso Y; Sugimachi K
    J Gastroenterol Hepatol; 1991; 6(5):476-80. PubMed ID: 1932669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eleven-year survey of safety and efficacy of endoscopic injection sclerotherapy using 2% sodium tetradecyl sulfate and contrast medium.
    Iwase H; Suga S; Shimada M; Yamada H; Horiuchi Y; Oohashi M
    J Clin Gastroenterol; 1996 Jan; 22(1):58-65. PubMed ID: 8776100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, controlled study of various agents for endoscopic injection sclerotherapy of bleeding canine gastric varices.
    Jutabha R; Jensen DM; See J; Machicado G; Hirabayashi K
    Gastrointest Endosc; 1995 Mar; 41(3):206-11. PubMed ID: 7789678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopic sclerotherapy in children.
    Dilawari JB; Chawla YK; Ramesh GN; Mitra SK; Walia BN
    J Gastroenterol Hepatol; 1989; 4(2):155-60. PubMed ID: 2490909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injection sclerotherapy preceded by esophageal tamponade versus immediate sclerotherapy in arresting active variceal bleeding: a prospective randomized trial.
    Lo GH; Lai KH; Ng WW; Tam TN; Lee SD; Tsai YT; Lo KJ
    Gastrointest Endosc; 1992; 38(4):421-4. PubMed ID: 1511814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of 1% sodium tetradecyl sulfate to a thrombogenic sclerosant cocktail for endoscopic sclerotherapy.
    Lyons SD; Sugawa C; Geller ER; Vandenberg DM
    Am Surg; 1988 Feb; 54(2):81-4. PubMed ID: 3257666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute esophageal variceal sclerotherapy. Results of a prospective randomized controlled trial.
    Larson AW; Cohen H; Zweiban B; Chapman D; Gourdji M; Korula J; Weiner J
    JAMA; 1986 Jan 24-31; 255(4):497-500. PubMed ID: 3510333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of endoscopic variceal sclerotherapy on gas exchange and hemodynamics in humans.
    Bailey-Newton RS; Connors AF; Bacon BR
    Gastroenterology; 1985 Aug; 89(2):368-73. PubMed ID: 3874111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of chronic endoscopic variceal sclerotherapy on portal pressure in cirrhotics.
    Korula J; Ralls P
    Gastroenterology; 1991 Sep; 101(3):800-5. PubMed ID: 1860642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Octreotide infusion or emergency sclerotherapy for variceal haemorrhage.
    Sung JJ; Chung SC; Lai CW; Chan FK; Leung JW; Yung MY; Kassianides C; Li AK
    Lancet; 1993 Sep; 342(8872):637-41. PubMed ID: 8103145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.